According to the research report titled ‘Global Primary Cell Culture Market Size study, by Product (Primary Cells, Reagents and Supplements, Media), Cell Type (Animal Cells, Human Cells), Separation Method (Explant Method, Enzymatic Degradation, Mechanical Separation, Others) Application (Tissue Culture & Tissue Engineering, Vaccine Production, Gene Therapy and Regenerative Medicine, Toxicity Testing and Drug Screening, Cancer Research, Model System, Virology, Prenatal Diagnosis, Stem Cell Therapy, Others) and Regional Forecasts 2020-2027’, available with Market Study Report, global primary cell culture market size was worth USD 3.05 billion in 2019 and is expected to expand at a CAGR of 11.06% over 2021-2027, subsequently accumulating USD 7.34 billion by the end of the assessment period.
 

Increasing investment in research & development, advances in genetic research process, and increasing cases of cancer and cardiovascular diseases are propelling global primary cell culture market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3793434/
 

The World Health Organization (WHO) cited that 71.0 million individuals worldwide were infected with chronic hepatitis C in 2020. According to the National Cancer Institute, the number of cancer survivors in the United States reached 16.9 million in January 2019, and this number is projected to increase to 22.2 million by 2030. New product launches are technological disruptions will continue to create opportunities in the upcoming years.
 

For the unaware, cell culture is the method of collecting cells from plant or animal source and cultivating them in a laboratory setting. This artificial environment contains nutrients necessary for cell growth and proliferation, such as appropriate temperature, pH, gases, and humidity, which aids researchers in their investigation into cell characteristics and microbiology.
 

Growing research and demand for stem cell therapy, and emerging chronic diseases are further boosting worldwide primary cell culture industry expansion.
 

Despite the favorable business outlook, lack of expertise and high capital investment required are likely to negatively impact the industry remuneration over the study period.
 

Elaborating on the geographical ambit, Europe presently holds major portion of global primary cell culture market share, creditable to presence of well-established healthcare infrastructure, along with booming elderly population, and affordable urgent care services in the region.
 

Meanwhile, Asia Pacific industry is projected to grow substantially over 2020-2027, owing to improving medical infrastructure, increasing incidences of injuries, and rising disposable income.
 

Prominent players in global primary cell culture market sphere are Axol Bioscience Ltd., MatTek Corporation, Fujifilm Irvine Scientific Inc., ATCC (American Type Culture Collection), PromoCell GmbH, Danaher Corporation, Corning Incorporated, Merck & Co. Inc., Lonza Group, and Thermo Fisher Scientific Inc.